Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes.

MLA

Brammer, J. E., et al. “Multi-Center Analysis of the Effect of T-Cell Acute Lymphoblastic Leukemia Subtype and Minimal Residual Disease on Allogeneic Stem Cell Transplantation Outcomes.” Bone Marrow Transplantation, vol. 52, no. 1, Jan. 2017, pp. 20–27. EBSCOhost, https://doi.org/10.1038/bmt.2016.194.

APA

Brammer, J. E., Saliba, R. M., Jorgensen, J. L., Ledesma, C., Gaballa, S., Poon, M., Maziarz, R. T., Champlin, R. E., Hosing, C., & Kebriaei, P. (2017). Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes. Bone Marrow Transplantation, 52(1), 20–27. https://doi.org/10.1038/bmt.2016.194

Chicago

Brammer, J E, R M Saliba, J L Jorgensen, C Ledesma, S Gaballa, M Poon, R T Maziarz, R E Champlin, C Hosing, and P Kebriaei. 2017. “Multi-Center Analysis of the Effect of T-Cell Acute Lymphoblastic Leukemia Subtype and Minimal Residual Disease on Allogeneic Stem Cell Transplantation Outcomes.” Bone Marrow Transplantation 52 (1): 20–27. doi:10.1038/bmt.2016.194.